Fosun Pharma and Henlius Entered into an… Leave a comment

PRINCETON, N.J., Jan. 7, 2023 /PRNewswire/ — Fosun Pharma (600196.SH, 02196.HK) has recently entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc….

Source